Multiplex Methionine Modulating Hydrogel for Cancer Metabolic Therapy
Advanced Materials · 2025-07 · 37 (30)
DOI: 10.1002/adma.202420445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 16.05.2025. Verfasst von Siyu Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Hauptthemen laut MEDLINE: Methionine, Hydrogels, Antineoplastic Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
The reliance on high levels of methionine by tumor cells provides an attractive target for cancer treatment. However, systemic methionine blockade may raise concerns about potential side effects given the broad and essential functions of methionine in cellular metabolism. Here, a combined drug delivery platform for multilayered constraint of methionine within tumor lesions is developed. Small molecule inhibitors PF9366 and adenosine dialdehyde are encapsulated by tumor cell‐targeting nanoparticles (NPs) to achieve a cascaded blockage of intracellular methionine metabolism. These NPs are further co‐loaded with the extracellular methionine uptake inhibitor JPH203 into a type of reactive oxygen species‐sensitive hydrogel, assembling the multiplex methionine modulating hydrogel (3 M Gel). In murine models of triple‐negative breast cancer (TNBC), hepatocellular carcinoma, and colorectal cancer, the in situ formed 3 M Gel exhibits superior efficacy in restricting S‐adenosyl methionine generation and histone methylation, stimulating immunogenic cell death in tumor cells, thereby eliciting potent innate and adaptive immune responses to restrain tumor progression. Moreover, remodeling of the tumor microenvironment by 3 M Gel overcomes immune checkpoint blockade resistance in TNBC. This study presents a localized triple regulation strategy and paves a new path for amino acid starvation‐based cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
- College of Chemistry and Materials Science, The Education Ministry Key Lab of Resource Chemistry, Joint International Research Laboratory of Resource Chemistry of Ministry of Education, Shanghai Key Laboratory of Rare E…
ORCID-Profile: Daoxia Guo, Haiyun Song
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Shanghai Municipal Health Commission
- China Postdoctoral Science Foundation
- Postdoctoral Fellowship Program of CPSF
- National Key Research and Development Program of China
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Ma, S., Zhu, W., Ji, X., Liu, C., Chen, N., Guo, D., & Song, H. (2025). Multiplex Methionine Modulating Hydrogel for Cancer Metabolic Therapy. Advanced Materials, 37(30). https://doi.org/10.1002/adma.202420445
Vancouver
Ma S, Zhu W, Ji X, Liu C, Chen N, Guo D, et al. Multiplex Methionine Modulating Hydrogel for Cancer Metabolic Therapy. Advanced Materials. 2025;37(30). doi:10.1002/adma.202420445
BibTeX
@article{Ma2025,
author = {Ma, Siyu and Zhu, Wen and Ji, Xiaoyuan and Liu, Chang and Chen, Nan and Guo, Daoxia and Song, Haiyun},
title = {Multiplex Methionine Modulating Hydrogel for Cancer Metabolic Therapy},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {30},
doi = {10.1002/adma.202420445}
}
EUVIMED